Inhibitory effects of caffeine analogues on neoplastic transformation: Structure-activity relationship

Carcinogenesis

Volumn 29, Issue 6, 2008, Pages 1228-1234

  Rogozin, Evgeny A ^a   Lee, Ki Won ^a,b   Kang, Nam Joo ^a   Yu, Haoyu ^a   Nomura, Masaaki ^c   Miyamoto, Ken Ichi ^d   Conney, Allan H ^e   Bode, Ann M ^a   Dong, Zigang ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Konkuk University   (South Korea)

^c HOKURIKU UNIVERSITY   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

^e RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ETHYL 3 METHYLXANTHINE; 1 ETHYL 3 PROPYLXANTHINE; 1 ETHYLXANTHINE; 1 METHYLXANTHINE; 1 PROPYL 3 ETHYLXANTHINE; 1 PROPYL 3 METHYLXANTHINE; 1 PROPYLXANTHINE; 1,3 DIETHYLXANTHINE; 1,3 DIPROPYLXANTHINE; 1,3,7 TRIALKYLXANTHINE DERIVATIVE; 1,7 DIMETHYL 3 PROPYLXANTHINE; 3 ETHYLXANTHINE; 3 METHYLXANTHINE; 3 PROPYL 7 ETHYLXANTHINE; 3 PROPYL 7 METHYLXANTHINE; 3,7 DIPROPYLXANTHINE; 7 METHYLXANTHINE; ALKYL GROUP; CAFFEINE; CAFFEINE DERIVATIVE; ENPROFYLLINE; EPIDERMAL GROWTH FACTOR; PARAXANTHINE; PHORBOL 13 ACETATE 12 MYRISTATE; RAS PROTEIN; THEOBROMINE; THEOPHYLLINE; TRANSCRIPTION FACTOR AP 1; UNINDEXED DRUG; XANTHINE DERIVATIVE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL TRANSFORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; EPIDERMIS CELL; IC 50; MALIGNANT TRANSFORMATION; MOUSE; MULTIPLE REGRESSION; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TRANSACTIVATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CAFFEINE; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; MICE; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTOR AP-1;

EID: 46949092136     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn016     Document Type: Article

References (43)

1. Epifano,F. et al. (2007) Chemistry and pharmacology of oxyprenylated secondary plant metabolites. Phytochemistry, 68 939-953.
2. Bode,A.M. et al. (2006) Molecular and cellular targets. Mol. Carcinog., 45, 422-430.
3. Fedorov,S.N. et al. (2006) Evaluation of cancer-preventive activity and structure-activity relationships of 3-demethylubiquinone Q2, isolated from the ascidian Aplidium glabrum, and its synthetic analogs. Pharm. Res., 23, 70-81.
4. Somei,M. et al. (2005) Simple indole alkaloids and those with a non-rearranged monoterpenoid unit. Nat. Prod. Rep., 22, 73-103.
5. Fedorov,S.N. et al. (2004) Marine alkaloid polycarpine and its synthetic derivative dimethylpolycarpine induce apoptosis in JB6 cells through p53- and caspase 3-dependent pathways. Pharm. Res., 21 2307-2319.
6. Huang,M.T. et al. (1997) Effects of tea, decaffeinated tea, and caffeine on UVB light-induced complete carcinogenesis in SKH-1 mice: demonstration of caffeine as a biologically important constituent of tea. Cancer Res., 57, 2623-2629.
7. Lu,G. et al. (2006) Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. Cancer Res., 66, 11494-11501.
8. Nishikawa,A. et al. (1995) Effects of caffeine on glandular stomach carcinogenesis induced in rats by N-methyl-N'-nitro-N-nitrosoguanidine and sodium chloride. Food Chem. Toxicol., 33, 21-26.
9. Hosaka,S. et al. (1984) Suppressive effect of caffeine on the development of hepatic tumors induced by 2-acetylaminofluorene in ACI rats. Gann, 75, 1058-1061.
10. Lou,Y.R. et al. (1999) Effects of oral administration of tea, decaffeinated tea, and caffeine on the formation and growth of tumors in high-risk SKH-1 mice previously treated with ultraviolet B light. Nutr. Cancer, 33, 146-153.
11. Nomura,M. et al. (2005) Inhibition of epidermal growth factor-induced cell transformation and Akt activation by caffeine. Mol. Carcinog., 44, 67-76.
12. He,Z. et al. (2003) Induction of apoptosis by caffeine is mediated by the p53, Bax, and caspase 3 pathways. Cancer Res., 63, 4396-4401.
13. Jang,M.H. et al. (2002) Caffeine induces apoptosis in human neuroblastoma cell line SK-N-MC. J. Korean Med. Sci., 17, 674-678.
14. Qi,W. et al. (2002) Caffeine induces TP53-independent G(1)-phase arrest and apoptosis in human lung tumor cells in a dose-dependent manner. Radiat. Res., 157, 166-174.
15. Hirsh,L. et al. (2004) Phosphodiesterase inhibitors as anti-cancer drugs. Biochem. Pharmacol., 68, 981-988.
16. Yoshida,Y. et al. (2000) Theophylline and cisplatin synergize in down regulation of BCL-2 induction of apoptosis in human granulosa cells transformed by a mutated p53 (p53 val135) and Ha-ras oncogene. Int. J. Oncol., 17, 227-235.
17. Sadzuka,Y. et al. (2000) Effects of 1-methyl-3-propyl-7-butylxanthine (MPBX) on idarubicin-induced antitumor activity and bone marrow suppression. Jpn. J. Cancer Res., 91 651-657.
18. Sadzuka,Y. et al. (1998) 1-Methyl-3-propyl-7-butylxanthine, a novel biochemical modulator, enhances therapeutic efficacy of adriamycin. Jpn. J. Cancer Res., 89, 228-233.
19. Jiang,X. et al. (2000) Structure-activity relationships for G2 checkpoint inhibition by caffeine analogs. Int. J. Oncol., 16 971-978.
20. Bernstein,L.R. et al. (1989) AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science, 244, 566-569.
21. Dong,Z. et al. (1994) Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl Acad. Sci. USA, 91, 609-613.
22. Huang,C. et al. (1998) Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc. Natl Acad. Sci. USA, 95, 156-161.
23. Dong,Z. et al. (2002) Harvesting cells under anchorage-independent cell transformation conditions for biochemical analyses. Sci. STKE 2002, PL7.
24. Huang,C. et al. (1997) Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc. Natl Acad. Sci. USA, 94, 5826-5830.
25. Miyamoto,K.I. et al. (1992) Selective brouchodilators, from 1-(5′-oxohexyl) xanthines. J. Pharm. Pharmacol., 44, 888-892.
26. Miyamoto,K. et al. (1993) Bronchodilator activity of xanthine derivatives substituted with functional groups at the 1- or 7-position. J. Med. Chem., 36, 1380-1386.
27. Miyamoto,K. et al. (1994) Selective tracheal relaxation and phosphodiesterase-IV inhibition by xanthine derivatives. Eur. J. Pharmacol., 267, 317-322.
28. Sanae,F. et al. (1995) Structure-activity relationships of alkylxanthines: Alkyl chain elongation at the N1- or N7-position decreases cardiotonic activity in the isolated guinea pig heart. Jpn. J. Pharmacol., 69, 75-82.
29. Sakai,R. et al. (1992) Effects of alkyl substitutions of xanthine skeleton on bronchodilation. J. Med. Chem., 35, 4039-4044.
30. Levi-Schaffer,F. et al. (1991) Xanthines inhibit 3T3 fibroblast proliferation. Skin Pharmacol., 4, 286-290.
31. Belman,S. et al. (1974) Phorbol-12-myristate-13-acetate effect on cyclic adenosine 3′,5′-monophosphate levels in mouse skin and inhibition of phorbol-myristate-acetate-promoted tumorigenesis by theophylline. Cancer Res., 34, 3446-3455.
32. Hashimoto,T. et al. (2004) Caffeine inhibits cell proliferation by G0/G1 phase arrest in JB6 cells. Cancer Res., 64, 3344-3349.
33. Zachos,G. et al. (1997) Expression of ras proto-oncogenes: regulation and implications in the development of human tumors. Crit. Rev. Oncol. Hematol., 26, 65-75.
34. Barone,J.J. et al. (1996) Caffeine consumption. Food Chem. Toxicol., 34, 119-129.
35. Lelo,A. et al. (1986) Assessment of caffeine exposure: Caffeine content of beverages, caffeine intake, and plasma concentrations of methylxanthines. Clin. Pharmacol. Ther., 39, 54-59.
36. MAFF. (1997) Survey of Caffeine and Other Methylxanthines in Energy Drinks and Other Caffeine-Containing Products. MAFF Publications, London Vol. Food Surveillance Information Sheet No. 103.
37. Lipinski,C.A. et al. (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 46, 3-26.
38. AndrewsP.R. et al. (1984) Functional group contributions to drug-receptor interactions. J. Med. Chem., 27, 1648-1657.
39. Lee,K.W. et al. (2006) The roles of polyphenols in cancer chemoprevention. Biofactors, 26, 105-121.
40. Angel,P. et al. (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072, 129-157.
41. Dong,Z. et al. (2001) Effects of tea polyphenols on the signal transduction pathways. Adv. Exp. Med. Biol., 492, 55-67.
42. Bode,A.M. et al. (2004) Cancer prevention by food factors through targeting signal transduction pathways. Nutrition, 20, 89-94.
43. Sun,Y. et al. (1993) No point mutation of Ha-ras or p53 genes expressed in preneoplastic-to-neoplastic progression as modeled in mouse JB6 cell variants. Mol. Carcinog., 8, 49-57.